Page 106 of 106 FirstFirst ... 65696979899100101102103104105106
Results 1,051 to 1,053 of 1053

Thread: Spinal Cord Injury Articles Posted by Manouli

  1. #1051
    Science
    JNCASR’s molecule improves recovery after spinal cord injury

    Spinal cord injury can now be repaired using a small molecule (TTK21) synthesised by a team led by Tapas Kumar Kundu from the Molecular Biology and Genetics Unit at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru, a study has found. The small molecule tested both on mice and rat models promoted regeneration and growth of new sensory and motor axons leading to recovery of sensory and motor functions in the animals with spinal cord injury.
    more...
    https://www.thehindu.com/sci-tech/sc...le26830296.ece

  2. #1052
    Senior Member lunasicc42's Avatar
    Join Date
    Oct 2004
    Location
    Lutz, Fl USA*********C456
    Posts
    2,246
    Quote Originally Posted by manouli View Post
    Science
    JNCASR’s molecule improves recovery after spinal cord injury

    Spinal cord injury can now be repaired using a small molecule (TTK21) synthesised by a team led by Tapas Kumar Kundu from the Molecular Biology and Genetics Unit at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru, a study has found. The small molecule tested both on mice and rat models promoted regeneration and growth of new sensory and motor axons leading to recovery of sensory and motor functions in the animals with spinal cord injury.
    more...
    https://www.thehindu.com/sci-tech/sc...le26830296.ece

    This study is on acute injury rats
    "That's not smog! It's SMUG!! " - randy marsh, southpark

    "what???? , you don't 'all' wear a poop sac?.... DAMNIT BONNIE, YOU LIED TO ME ABOUT THE POOP SAC!!!! "


    2010 SCINet Clinical Trial Support Squad Member
    Please join me and donate a dollar a day at http://justadollarplease.org and copy and paste this message to the bottom of your signature

  3. #1053
    REPROCELL and Q Therapeutics to co-develop clinical grade iGRP for treatment of various CNS disorders. REPROCELL will manufacture clinical grade iGRP at the cGMP suite to conduct preclinical safety/efficacy studies and clinical trials.

    REPROCELL Inc. today announced that it has established the current good manufacturing practice (cGMP) cell processing suite at Life Innovation Center (LIC) in Tonomachi area in Kawasaki city for production of iPS Cell-derived Glial Progenitors (iGRP) for treatment of CNS disorders. The suite has been designed to support Clinical Trials of cell therapy products.
    REPROCELL has been jointly developing iGRP with Q Therapeutics Inc. (Utah, USA) for treatment of various intractable CNS diseases and injuries. The target indications of iGRP include Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS) Transverse Myelitis (TM), Spinal Cord Injuries (SCI) and Stroke. REPROCELL will manufacture clinical grade iGRP at the suite to conduct preclinical safety/efficacy studies and clinical trials.
    In addition, REPROCELL plans to manufacture and store clinical grade iPS Cell Bank as raw material for iPS Cell-derived cellular products at the suite according to US/EU/Japan regulations and guidelines and plans to support academia and industry for manufacturing materials for animal studies and clinical trials.
    read....
    https://www.prweb.com/releases/repro...eb16308451.htm

Similar Threads

  1. Replies: 0
    Last Post: 08-14-2005, 09:16 AM
  2. New articles posted to Research Forums.
    By Wise Young in forum Cure
    Replies: 1
    Last Post: 04-15-2004, 11:41 AM
  3. Replies: 0
    Last Post: 01-14-2004, 12:00 PM
  4. Replies: 8
    Last Post: 05-15-2003, 02:05 AM
  5. Replies: 1
    Last Post: 05-12-2002, 04:07 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •